UBS Group’s Incyte INCY Stock Holding History

UBS Group’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$210K	Hold	2,232	–	–	﹤0.01%	6611
2025 Q4	$220K	Buy	+2,232	New	+$216K	﹤0.01%	6526
2020 Q2	–	Sell	-435,000	Closed	-$31.9M	–	8140
2020 Q1	$31.9M	Hold	435,000	–	–	0.02%	754
2019 Q4	$38M	Hold	435,000	–	–	0.01%	934
2019 Q3	$32.3M	Hold	435,000	–	–	0.01%	925
2019 Q2	$37M	Sell	435,000 -2,700	-0.6%	-$217K	0.01%	833
2019 Q1	$37.6M	Buy	437,700 +2,700	+0.6%	+$220K	0.02%	788
2018 Q4	$27.7M	Buy	435,000 +235,000	+118%	+$15.3M	0.01%	875
2018 Q3	$13.8M	Hold	200,000	–	–	0.01%	1500
2018 Q2	$13.4M	Sell	200,000 -73,000	-27%	-$4.99M	0.01%	1481
2018 Q1	$22.7M	Buy	273,000 +73,000	+37%	+$6.58M	0.01%	1062
2017 Q4	$18.9M	Hold	200,000	–	–	0.01%	1240
2017 Q3	$23.3M	Buy	+200,000	New	+$25.3M	0.01%	1020
2016 Q1	–	Sell	-2,300	Closed	-$249K	–	7871
2015 Q4	$249K	Hold	2,300	–	–	﹤0.01%	4500
2015 Q3	$254K	Hold	2,300	–	–	﹤0.01%	4447
2015 Q2	$240K	Sell	2,300 -2,000	-47%	-$207K	﹤0.01%	4718
2015 Q1	$394K	Sell	4,300 -9,100	-68%	-$752K	﹤0.01%	4333
2014 Q4	$980K	Buy	+13,400	New	+$875K	﹤0.01%	3582

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group's INCY Position: Q1 2026 in Review

UBS Group increased its Incyte (INCY) stake by 67% in Q1 2026, buying an estimated $45.7M and bringing the position to 1,138,004 shares worth $107M. The position accounts for 0.02% of the portfolio, ranked #1001.

UBS Group first reported a position in INCY in Q4 2014 and has held it in 46 quarters since. The position peaked at $306M in Q2 2018. 811 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

UBS Group held 1,138,004 shares of Incyte worth $107M as of Q1 2026.
UBS Group bought 457,921 Incyte shares in Q1 2026, an estimated $45.7M.
Incyte made up 0.02% of UBS Group's portfolio in Q1 2026, its #1001 holding.
UBS Group first reported a position in Incyte in Q4 2014 and has held it in 46 quarters since.
UBS Group's Incyte position peaked at $306M in Q2 2018.
811 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.